多亏了冷冻干燥技术，我们可以在户外冲泡出浓郁的咖啡，也可以在办公室制作带有果肉的橙汁。随着冻干技术进入医学界，我们未来还能足不出户，在 家还原出新鲜的……粑粑。 先别笑，这真的是正经研究！ 在英国，一支科研团队正试图利用大便冻干，应对病原体抗药性给人类健康带来的威胁。 冻干技术是一种将物料冻结后，在真空环境中使冰直接升华成水蒸气，实现物料脱水干燥的方法（图片来源：empire freezing drying） 看似无解之时，科学家发现一个健康的肠道菌群系统会抑制超级细菌增长，将其控制在相对安全的水平。那么，如何才能将正常运作的肠道菌群植入患者 体内呢？ 当我们因细菌感染生病时，有时会使用抗生素治疗。但在治疗过程中，病原体细菌可能会发生基因突变，使抗生素对其失效，这就是所谓的细菌耐药性。 当一种病原体细菌同时对多种抗生素具有耐药性时，它就成为了医生口中的"超级细菌"。 很多超级细菌栖息于人类肠道中，当其他菌群被抗生素杀得溃不成军时，超级细菌却凭借着耐药性"独领风骚"，越来越强。这导致患者的病症屡治不愈， 反复发作，甚至到最后无药可医。 这是一台小型冻干机，科学家在干燥真菌孢子试剂（图片来源：Wikipedia ...

★ 宏观动态 ★ 广东省人民政府办公厅印发《广东省促进经济持续向好服务做强国内大循环工作方案》，其中提及，充分用 好"240小时过境免签"和离境退税"即买即退"等政策，进一步优化通关、支付等服务，有效扩大入境消费。加 快广州、深圳市内免税店建设，力争在2025年第三季度内开业。 央行等六部门：实施好货币政策 加强逆周期和跨周期调节 近日，中国人民银行、国家发展改革委、财政部、商务部、金融监管总局、中国证监会等六部门联合印发《关 于金融支持提振和扩大消费的指导意见》，其中提出，夯实宏观经济基础，稳定消费预期。加大实体经济支持 力度，强化金融与财政、产业等政策协同联动。实施好货币政策，加强逆周期和跨周期调节，综合运用准备 金、再贷款再贴现、公开市场操作等多种货币政策工具，保持流动性充裕，持续推动社会综合融资成本下降。 实施好财政政策，更好发挥消费在畅通国民经济循环、拉动经济增长中的积极作用。健全投资和融资相协调的 资本市场功能，推动中长期资金入市，促进资本市场稳定发展。 央行等六部门：设立服务消费与养老再贷款，额度5000亿元 近日，中国人民银行、国家发展改革委、财政部、商务部、金融监管总局、中国证监会等六部门联 ...

海南橡胶（601118）公告，2025年第1号台风"蝴蝶"(强热带风暴级)登陆海南，造成公司部分分子公司的 橡胶等生物资产及配套生产设施等固定资产不同程度损失。初步统计，受灾橡胶及非胶、防护林等生物 性资产约35万株，预计全年干胶减产约0.26万吨。目前，受灾基地分公司已全部恢复生产经营。主要财 产已投保，保险公司正在积极进行保险理赔相关工作。预计本次灾害对公司2025年经营业绩有一定影 响，但不会对公司未来发展造成重大不利影响。 ...

Core Viewpoint - Jiangtian Technology has restarted its IPO process on the Beijing Stock Exchange, indicating a renewed effort to list after previous challenges related to financial updates and compliance issues [1][5]. Company Overview - Jiangtian Technology, established in 1995, specializes in the research, production, and sales of label printing products, including film and paper-based self-adhesive labels, widely used in various consumer sectors such as beverages, personal care, and food [3][4]. - The company has notable clients in the beauty sector, including Unilever, Procter & Gamble, and others in the daily chemical field like Blue Moon and Naixis [3]. Financial Performance - In 2024, Jiangtian Technology reported a total revenue of 538 million CNY, a 6% increase year-on-year, with a net profit of 101 million CNY, reflecting a 5.55% growth [5][6]. - The company's gross margin decreased from 30.95% to 29.97% in 2024, indicating a slight decline in profitability [6][8]. - The revenue growth was primarily driven by the film-based self-adhesive labels, which generated 428 million CNY, accounting for 79.58% of total revenue [8]. Client Base - The top five clients in 2024 included Yangshengtang/Nongfu Spring, Xintianli, Blue Moon, Haitian Flavor Industry, and Unilever, with Yangshengtang/Nongfu Spring contributing 35.33% of total sales [7]. Industry Context - The packaging materials industry is facing intense price competition due to low entry barriers and a fragmented competitive landscape, leading to declining profit margins across the sector [9]. - Jiangtian Technology's IPO restart reflects a structural opportunity in the packaging materials industry, driven by consumption upgrades and green packaging trends, suggesting a potential for valuation reconstruction for companies with smart transformation capabilities and ESG practices [9].

答：尊敬的投资者，您好，公司坚持以产品服务为核心的 企业战略，完善产品服务体系。在商纸、印刷、标签及版权的 细分行业里为客户提供有特色的产品及服务。2025 年公司布局 华南工厂扩大产能的同时从环保及产品创新出发开发新产品， 扩大企业客户，提升公司盈利能力。谢谢您的关注。 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 ■业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 形式 ☐现场 ■网上 ☐电话会议 参与单位名称及 人员姓名 投资者网上提问 时间 2025 年 5 月 15 日（星期四）下午 14:30-17:00 地点 公司通过 全 景 网 " 投 资 者 关 系 互 动 平 台 " （https://ir.p5w.net）采用网络远程的方式召开业绩说明会 上市公司接待人 员姓名 1、董事长兼总经理张杰先生 2、董事、副总经理兼财务总监许志强先生 3、独立董事江曙晖女士 4、副总经理兼董事会秘书谢蓉女士 投资者关系活动 主要内容介绍 投资者提出的问题及公司回复情况 公司就投资者在本次说明会中提出的问题进行了回复： 1、问：目前公司涉及到些诉讼，进展如何 ...

Core Viewpoint - Jiangtian Technology's IPO review status has been changed to "suspended" due to financial report updates, despite the company completing its 2024 annual report disclosure within a month. The suspension status is expected to continue in the short term [2]. Company Overview - Jiangtian Technology, established in 1992, specializes in film-based and paper-based self-adhesive labels and other printing products, with key clients including Nongfu Spring, Haitian Flavor Industry, and Blue Moon [5]. Financial Performance - Revenue from 2022 to 2024 was reported as follows: 338 million yuan, 508 million yuan, and 538 million yuan, with year-on-year growth rates of 10.68%, 32.17%, and 6.00% respectively. Net profit for the same period was 74 million yuan, 96 million yuan, and 80 million yuan, with growth rates of 21.50%, 29.56%, and 5.55% respectively [5]. - In Q1 2025, the company achieved revenue of 134 million yuan, a slight increase of 2.12% year-on-year, while net profit was 26 million yuan, reflecting a decline of 9.66%, marking the second consecutive quarter of negative growth [5]. Client Dependency and Risks - The company faces operational risks related to high client dependency, which may lead to loss of pricing power and increased substitution risks. These concerns have been highlighted by external observers [5]. - The 2024 annual report correction revealed that the top five clients accounted for significant sales proportions, with the largest client, Nongfu Spring, at 35.33%. After the correction, Unilever became the fifth-largest client with a sales proportion of 3.05%, surpassing the previous client by 1.34 percentage points [6]. Internal Control Issues - Jiangtian Technology has encountered internal control issues during the annual report disclosure process, raising questions about its IPO prospects amid declining performance [6].